# Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

> **NCT00303407** · — · TERMINATED · sponsor: **University Hospital, Geneva**

## Conditions studied

- Cancer
- Venous Thromboembolism

## Interventions

- **DRUG:** nadroparin

## Key facts

- **NCT ID:** NCT00303407
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2002-07
- **Target enrollment:** — (—)
- **Last updated:** 2006-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00303407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00303407, "Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00303407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*